Toward integrating the molecular mechanisms and recent progress in the design of RAGE inhibitors, in this perspective review we will outline the chemistry and biology of AGE–RAGE interactions and emerging small molecule-based therapeutical candidates for treating neurological disorders. Here, AGER is linked to nervous system disorder.